Regulations of ABCB1 and ABCG2 expression through MAPK pathways in acute lymphoblastic leukemia cell lines

Anticancer Research

Volumn 33, Issue 12, 2013, Pages 5317-5324

  Tomiyasu, Hirotaka ^a   Watanabe, Manabu ^b   Sugita, Kanji ^c   Goto Koshino, Yuko ^a   Fujino, Yasuhito ^a   Ohno, Koichi ^a   Sugano, Sumio ^b   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

ABCG2; ALL; BCRP; MAPK; Multidrug resistance

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; C JUN NH2 TERMINAL KINASE; ENZYME; LUNG RESISTANCE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ABCB1 GENE; ABCC1 GENE; ABCG2 GENE; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LRP GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR GENE; UPREGULATION;

EID: 84891448110     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Dores GM, Devesa SS, Curtis RE, Linet MS and Morton LM: Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood 119: 34-43, 2012.
2. Swerts K, De Moerloose B, Dhooge C, Laureys G, Benoit Y and Philippe J: Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukaemia. Eur J Cancer 42: 295-309, 2006.
3. Gimenez-Bonafe P, Tortosa A and Perez-Tomas R: Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets 9: 320-340, 2009.
4. Harris AL and Hochhauser D: Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 31: 205-213, 1992.
5. Higgins CF: Multiple molecular mechanisms for multidrug resistance transporters. Nature 446: 749-757, 2007.
6. Modok S, Mellor HR and Callaghan R: Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Curr Opin Pharmacol 6: 350-354, 2006.
7. Han K, Kahng J, Kim M, Lim J, Kim Y, Cho B, Kim HK, Min WS, Kim CC, Lee KY, Kim BK and Kang CS: Expression of functional markers in acute nonlymphoblastic leukemia. Acta Haematol 104: 174-180, 2000.
8. van der Kolk DM, Vellenga E, Scheffer GL, Muller M, Bates SE, Scheper RJ and de Vries EG: Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia. Blood 99: 3763-3770, 2002.
9. Dalton WS, Crowley JJ, Salmon SS, Grogan TM, Laufman LR, Weiss GR and Bonnet JD: A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study. Cancer 75: 815-820, 1995.
10. Kourti M, Vavatsi N, Gombakis N, Sidi V, Tzimagiorgis G, Papageorgiou T, Koliouskas D and Athanassiadou F: Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. Int J Hematol 86: 166-173, 2007.
11. Suvannasankha A, Minderman H, O'Loughlin KL, Nakanishi T, Ford LA, Greco WR, Wetzler M, Ross DD and Baer MR: Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: Frequent expression and possible correlation with shorter disease-free survival. Br J Haematol 127: 392-398, 2004.
12. Shen H, Xu W, Luo W, Zhou L, Yong W, Chen F, Wu C, Chen Q and Han X: Up-regulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma. Exp Hematol 39: 558-569, 2011.
13. Sui H, Zhou S, Wang Y, Liu X, Zhou L, Yin P, Fan Z and Li Q: COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-JUN at Ser63/73 in colorectal cancer. Carcinogenesis 32: 667-675, 2011.
14. Imai Y, Ohmori K, Yasuda S, Wada M, Suzuki T, Fukuda K and Ueda Y: Breast cancer resistance protein/ABCG2 is differentially regulated downstream of extracellular signal-regulated kinase. Cancer Sci 100: 1118-1127, 2009.
15. Zhu MM, Tong JL, Xu Q, Nie F, Xu XT, Xiao SD and Ran ZH: Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer. PLoS One 7: e41763, 2012.
16. Tomiyasu H, Watanabe M, Goto-Koshino Y, Fujino Y, Ohno K, Sugano S and Tsujimoto H: Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines. Leuk Lymphoma 54: 1309-1315, 2013.
17. Yamazaki H, Nishida H, Iwata S, Dang NH and Morimoto C: CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. Biochem Biophys Res Commun 383: 172-177, 2009.
18. Nishida H, Yamazaki H, Yamada T, Iwata S, Dang NH, Inukai T, Sugita K, Ikeda Y and Morimoto C: CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells. Biochem Biophys Res Commun 382: 57-62, 2009.
19. Tomiyasu H, Goto-Koshino Y, Takahashi M, Fujino Y, Ohno K and Tsujimoto H: Quantitative analysis of mRNA for 10 different drug resistance factors in dogs with lymphoma. J Vet Med Sci 72: 1165-1172, 2010.
20. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P and Gabert J: Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe Against Cancer Program. Leukemia 17: 2474-2486, 2003.
21. Yang JM, Vassil AD and Hait WN: Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the RAF-MAPK pathway. Mol Pharmacol 60: 674-680, 2001.
22. Zhang Z, Knoepp SM, Ku H, Sansbury HM, Xie Y, Chahal MS, Tomlinson S and Meier KE: Differential expression of FAK and PYK2 in metastatic and non-metastatic EL4 lymphoma cell lines. Clin Exp Metastasis 28: 551-565, 2011.
23. Tomiyasu H, Yuko G-K, Yasuhito F, Koichi O and Hajime T: Epigenetic regulation of the ABCB1 gene in drug-sensitive and drug-resistant lymphoid tumour cell lines obtained from canine patients. Vet J 2013. in press DOI: http://dx.doi.org/10.1016/j.tvjl.2013.10.022
24. El Azreq MA, Naci D and Aoudjit F: Collagen/β1 integrin signaling up-regulates the ABCC1/MRP-1 transporter in an ERK/MAPK-dependent manner. Mol Biol Cell 23: 3473-3484, 2012.